Two Sigma Securities’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
Other funds holding TELO
Two Sigma Securities's TELO Position: Q2 2026 in Review
Two Sigma Securities opened a new position in Telomir Pharmaceuticals (TELO) in Q2 2026: 12,616 shares worth $16.1K. The stake represents ﹤0.01% of the portfolio and ranks #1513 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TELO as recently as Q4 2025.
Two Sigma Securities first reported a position in TELO in Q2 2025 and has held it in 3 quarters since. The position peaked at $28.6K in Q2 2025. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.
- Two Sigma Securities held 12,616 shares of Telomir Pharmaceuticals worth $16.1K as of Q2 2026.
- Telomir Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
- Telomir Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1513 holding.
- Two Sigma Securities first reported a position in Telomir Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
- Two Sigma Securities's Telomir Pharmaceuticals position peaked at $28.6K in Q2 2025.
- 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.